Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):319–329. doi: 10.1097/QAI.0000000000001499

Table 1. Patient characteristics.

Total adults: 35561 Total children: 2601

Number* (%) Number* (%)

Median age at ART initiation, years 37, (IQR 30-46) 4.65, (IQR 1.02-9.75)

Sex
Male 21623 (60.8) 1299 (49.9)
Female 13935 (39.2) 1302 (50.1)
Unknown 3 (0.0) 0 (0.0)

Prior AIDS-defining illness
No 15508 (43.6) 164 (6.3)
Yes 2695 (7.6) 52 (2.0)
Unknown 17358 (48.8) 2385 (91.7)

Median Pre-ART CD4 count 218 cells/μL, (IQR 105-344) 15.89 percent, (IQR 8.70-23.24)

HIV mode of exposure
Homosexual/bisexual 8537 (24.0) 0 (0.0)
Heterosexual 14216 (40.0) 0 (0.0)
IDU 1639 (4.6) 0 (0.0)
Perinatal 0 (0.0) 2119 (81.5)
Other** 645 (1.8) 190 (7.3)
Unknown 10524 (29.6) 292 (11.2)

Region
Asia-Pacific 2121 (6.0) 291 (11.2)
Caribbean, Central and South America 3404 (9.6) 75 (2.9)
North America 14579 (41.0) 0 (0.0)
South Africa 15457 (43.5) 2235 (85.9)
*

Unless otherwise specified.

**

For children, “Other” includes sexual behaviour (184), sexual abuse (2), blood transfusion (2) and breastfeeding (2).

Abbreviations: IQR – interquartile range; ART- antiretroviral therapy; IDU – injecting drug users